Aurinia Pharmaceuticals Inc

Healthcare · Biotechnology

16.60$ +1.2% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

Aurinia Pharmaceuticals Inc (AUPH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 792 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet AUPH
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	33	57	220	208	200	190	176	168	158	146	165	151	151	324	315	295	462	464	417	386	360	543	507	482	488	471	452	549	555	548	517	524	549	551	505	503	528	752	724	792
Current Assets	17	41	204	192	185	175	162	154	144	133	151	139	139	315	298	278	412	419	372	350	329	513	478	453	460	443	424	416	426	425	398	410	440	447	406	409	439	492	480	541
Cash	12	40	199	180	88	166	131	132	115	118	140	131	135	306	274	232	249	272	157	122	58	232	133	152	86	94	89	82	46	49	64	33	37	83	66	53	73	80	41	180
Cash & Short-Term Investments	15	40	202	190	182	173	159	150	139	126	144	131	135	306	286	264	392	398	348	319	286	466	419	392	377	389	362	351	338	350	320	330	349	358	313	315	352	398	379	443
Receivables	0.1	0.1	0.1	0.3	0.4	0.1	0.2	0.3	0.8	0.2	0.4	0.2	0.5	0.4	3.5	0.5	1.1	1.0	1.2	4.4	9.8	15	20	18	42	13	19	19	38	24	29	26	36	37	40	40	31	41	49	41
Inventory	–	0.0	0.0	–	–	-0.1	0.0	–	–	–	0.0	–	–	–	–	–	6.8	14	16	17	19	19	26	26	25	25	32	33	33	40	40	39	39	39	46	47	45	46	46	45
Property, Plant & Equipment	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.4	0.4	0.1	5.9	6.4	9.7	4.8	4.8	10	4.6	9.8	4.3	9.3	3.8	8.6	3.8	3.7	–	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	16	16	15	15	14	14	14	13	13	13	12	12	12	8.9	11	11	11	9.3	9.9	9.3	8.9	8.4	7.9	7.3	6.8	6.4	6.1	5.7	5.3	5.0	4.8	4.6	4.5	4.4	4.2	4.0	3.9	3.8	3.6	3.4
Total Liabilities	13	21	47	29	32	24	24	26	32	33	25	25	27	26	52	56	63	56	47	54	62	64	59	58	65	65	61	157	163	170	157	159	161	173	155	167	162	170	156	177
Current Liabilities	4.8	7.9	8.3	3.6	6.9	8.2	5.3	5.1	6.9	7.3	6.5	7.3	14	11	14	17	24	32	21	29	38	41	34	35	42	46	42	62	74	77	71	77	79	98	68	78	76	94	87	100
Short-Term Debt	–	2.9	–	–	–	4.1	–	–	–	0.1	0.1	0.1	0.1	6.9	–	–	–	0.8	1.1	1.1	1.1	1.1	1.0	1.0	0.9	0.9	0.9	15	14	16	15	15	16	15	16	17	17	18	18	16
Accounts Payable	2.9	2.9	6.1	3.4	6.7	3.8	5.1	4.9	6.7	7.1	6.2	6.7	13	4.2	12	14	20	2.6	2.2	2.5	3.3	3.9	3.3	32	40	3.1	3.7	4.8	8.9	4.3	5.7	8.4	8.9	5.2	4.2	3.3	2.2	3.3	2.7	1.7
Long-Term Debt	–	9.1	–	–	–	12	–	–	–	–	0.3	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Shareholders' Equity	20	36	173	178	168	166	152	142	125	113	139	126	124	299	263	239	399	408	370	332	298	479	448	424	423	405	390	392	392	378	359	365	388	377	350	335	366	581	568	615
Retained Earnings	-273	-281	-333	-335	-349	-352	-367	-383	-401	-416	-428	-444	-463	-472	-556	-586	-620	-575	-626	-673	-723	-756	-794	-829	-838	-864	-891	-902	-915	-942	-953	-952	-938	-937	-913	-892	-860	-649	-615	-578
Shares Outstanding	36	57	57	83	84	83	84	84	85	85	90	92	92	98	112	113	122	118	127	128	128	132	142	142	142	142	143	143	143	144	144	144	146	148	139	143	136	139	138	134

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings